1. Home
  2. PRTA vs ETD Comparison

PRTA vs ETD Comparison

Compare PRTA & ETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • ETD
  • Stock Information
  • Founded
  • PRTA 2012
  • ETD 1932
  • Country
  • PRTA Ireland
  • ETD United States
  • Employees
  • PRTA N/A
  • ETD N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • ETD Home Furnishings
  • Sector
  • PRTA Health Care
  • ETD Consumer Discretionary
  • Exchange
  • PRTA Nasdaq
  • ETD Nasdaq
  • Market Cap
  • PRTA 809.8M
  • ETD 748.9M
  • IPO Year
  • PRTA N/A
  • ETD 1993
  • Fundamental
  • Price
  • PRTA $7.18
  • ETD $27.57
  • Analyst Decision
  • PRTA Buy
  • ETD Hold
  • Analyst Count
  • PRTA 9
  • ETD 2
  • Target Price
  • PRTA $51.71
  • ETD $30.00
  • AVG Volume (30 Days)
  • PRTA 1.6M
  • ETD 452.0K
  • Earning Date
  • PRTA 05-08-2025
  • ETD 05-05-2025
  • Dividend Yield
  • PRTA N/A
  • ETD 5.63%
  • EPS Growth
  • PRTA N/A
  • ETD N/A
  • EPS
  • PRTA N/A
  • ETD 2.25
  • Revenue
  • PRTA $137,935,000.00
  • ETD $622,924,000.00
  • Revenue This Year
  • PRTA N/A
  • ETD N/A
  • Revenue Next Year
  • PRTA $122.59
  • ETD $0.96
  • P/E Ratio
  • PRTA N/A
  • ETD $12.31
  • Revenue Growth
  • PRTA 54.55
  • ETD N/A
  • 52 Week Low
  • PRTA $8.00
  • ETD $24.55
  • 52 Week High
  • PRTA $25.42
  • ETD $35.62
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 30.36
  • ETD 51.36
  • Support Level
  • PRTA $6.47
  • ETD $26.19
  • Resistance Level
  • PRTA $8.08
  • ETD $27.75
  • Average True Range (ATR)
  • PRTA 0.72
  • ETD 0.89
  • MACD
  • PRTA 0.00
  • ETD -0.01
  • Stochastic Oscillator
  • PRTA 21.60
  • ETD 59.08

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

Share on Social Networks: